基于互联网的行为性咳抑制疗法对抗性慢性咳:一个随机对照试验
Jane R Salois1, Kassidi L Heinle1, Laurie J Slovarp1
1School of Speech, Language, Hearing, & Occupational Sciences, University of Montana, Missoula.
American journal of speech-language pathology
|August 14, 2025
概括
基于互联网的行为性咳抑制疗法 (IBCST) 有效地减少了成年人的慢性咳症状. 参与者对方便的在线治疗表示高度满意,显示生活质量的显著改善.
科学领域:
- 数字治疗学数字治疗学
- 行为医学是一种行为医学.
- 呼吸系统药物 呼吸系统药物
背景情况:
- 耐火性慢性咳显著影响生活质量.
- 慢性咳的有效和可获得的治疗选择有限.
研究的目的:
- 评估基于互联网的行为性咳抑制疗法 (IBCST) 的有效性.
- 为了探索患者对IBCST治疗耐火性慢性咳的经验.
主要方法:
- 一项为期5周的随机对照试验将IBCST与健康生活方式对照进行了比较.
- 参与者完成了莱斯特咳问卷 (LCQ) 和咳严重程度视觉模拟量表 (VAS).
- 定性访谈探讨了使用IBCST的用户体验.
主要成果:
- 72%的IBCST参与者在1周后显示出临床显著的LCQ改善,76%在1个月后显示出临床显著的LCQ改善.
- 虽然VAS得分有积极的趋势,但它们没有达到统计学意义.
- 定性数据显示,参与者对IBCST的方便性和有效性的满意度很高.
结论:
- IBCST是一种可行且有效的治疗耐火性慢性咳的方法.
- IBCST的疗效与其他行为性咳抑制疗法具有可比性.
- 这些发现支持将IBCST适应为数字治疗方法.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
310
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
310
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:17Drugs Used in Lower Respiratory Disorders: Overview
583
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
583